Literature DB >> 6831674

Quantitative analysis of the high-frequency components of the terminal portion of the body surface QRS in normal subjects and in patients with ventricular tachycardia.

P Denes, P Santarelli, R G Hauser, E F Uretz.   

Abstract

Quantitative analysis of the high-frequency components of the terminal portion of the surface QRS was performed in 42 normal subjects (group 1, ages 18-67 years, mean +/- SEM 34.7 +/- 2.2 years) and in 12 patients with symptomatic, sustained ventricular tachycardia (VT) (group 2, ages 48-76 years, mean 59 +/- 2.3 years). Signal averaging and high-pass, bidirectional digital filtering were used for analysis. The total duration of the QRS, the duration of the low-amplitude signals (less than 40 microV) in the terminal portion of the QRS and the amplitude of the signals in the last 40 and 50 msec of the QRS were measured at filter settings of 25 and 40 Hz. Reproducibility of the measurements was tested in 15 normal subjects by comparing results obtained from two consecutive recordings. Significant differences were found between normal subjects and VT patients for all four indexes at both 25- and 40-Hz filters. Specific values for each of the indexes were identified at the 40-Hz filtering, which could separate normal subjects from VT patients (20 microV for the amplitude of last 40 msec; 30 microV for the amplitude of last 50 msec; 120 msec for the total duration; and 39 msec for the low-amplitude signal of the filtered QRS). Using these values for the four indexes, respectively, 90%, 98%, 100% and 90% of the normal subjects and 83%, 83%, 58% and 83% for the VT group were correctly classified. The results show that the high-frequency analysis of the signal-averaged body surface QRS is a reliable, reproducible, noninvasive method for distinguishing patients with VT from normal subjects.

Entities:  

Mesh:

Year:  1983        PMID: 6831674     DOI: 10.1161/01.cir.67.5.1129

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  [Spectral analysis of the ECG for detecting late potentials as risk factors of life-threatening cardiac arrhythmias].

Authors:  R Haberl; G Steinbeck
Journal:  Klin Wochenschr       Date:  1990-08-02

2.  The electrophysiological cardiac ventricular substrate in patients after myocardial infarction: noninvasive characterization with electrocardiographic imaging.

Authors:  Phillip S Cuculich; Junjie Zhang; Yong Wang; Kavit A Desouza; Ramya Vijayakumar; Pamela K Woodard; Yoram Rudy
Journal:  J Am Coll Cardiol       Date:  2011-10-25       Impact factor: 24.094

3.  [Magnesium and calcium changes in serum and atrial muscle caused by open heart surgery and the effect of preoperative oral magnesium administration].

Authors:  S Ichikawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-03

4.  Intravenous streptokinase for acute myocardial infarction reduces the occurrence of ventricular late potentials.

Authors:  E W Chew; P Morton; J G Murtagh; M E Scott; D B O'Keeffe
Journal:  Br Heart J       Date:  1990-07

5.  Lack of impact of myocardial ischemia on the signal-averaged ECG assessment by time-domain analysis.

Authors:  Michael A E Schneider; Christoph A Nienaber
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

6.  Signal-averaged electrocardiogram may be a beneficial prognostic procedure in the postoperative follow-up tetralogy of fallot patients to determine the risk of ventricular arrhythmias.

Authors:  Rukiye Eker Omeroglu; Seref Olgar; Kemal Nisli
Journal:  Pediatr Cardiol       Date:  2007 May-Jun       Impact factor: 1.655

Review 7.  New Imaging Technologies To Characterize Arrhythmic Substrate.

Authors:  Antonio Dello Russo; Sergio Conti; Ghaliah Al-Mohani; Michela Casella; Francesca Pizzamiglio; Corrado Carbucicchio; Stefania Riva; Gaetano Fassini; Massimo Moltrasio; Fabrizio Tundo; Martina Zucchetti; Benedetta Majocchi; Eleonora Russo; Vittoria Marino; Fabrizio Bologna; Luigi Di Biase; Andrea Natale; Claudio Tondo
Journal:  J Atr Fibrillation       Date:  2014-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.